vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-668Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWАнтибиотик-ассоциированные диареи: проблемы и решенияANTIBIOTIC-ASSOCIATED DIARRHEA. PROBLEMS AND SOLUTIONS CONTINUOUS PROFESSIONAL EDUCATIONНырковаО.И.NyrkovaO.I.nirkova_oi@mail.ruБехтереваМ.К.BekhterevaM.K.neonatepearl@yandex.ruКветнаяА.С.KvetnayaA.S.neonatepearl@yandex.ruЖелезоваЛ.И.ZhelezovaL.I.neonatepearl@yandex.ruСанкт-Петербургская государственная педиатрическая медицинская академияSankt-Petersburg State Pediatric AcademyНИИ детских инфекции Федерального медико-биологического агентства России, Санкт-ПетербургScientific Research Center of Pediatric Infections Russian Federal Medical Biologic Agency201116092011105Вопросы современной педиатрии5462Copyright © Ныркова О., Бехтерева М., Кветная А., Железова Л., 20112011Ныркова О., Бехтерева М., Кветная А., Железова Л.Nyrkova O., Bekhtereva M., Kvetnaya A., Zhelezova L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/668ReferencesKim K.H., Fekety R., Batts D.H. et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic–associated colitis. J. Infect. Dis. 1981; 143: 42–50.Kim K.H., Fekety R., Batts D.H. et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic–associated colitis. J. Infect. Dis. 1981; 143: 42–50.Turck D., Bernet J.P., Marx J. et al. Incidence and risk factors of oral antibiotic associated diarrhea in an outpatient pediatric population. J. Pediatr. Gastroenterol. Nutr. 2003; 37 (1): 22–26.Turck D., Bernet J.P., Marx J. et al. Incidence and risk factors of oral antibiotic associated diarrhea in an outpatient pediatric population. J. Pediatr. Gastroenterol. Nutr. 2003; 37 (1): 22–26.Wistrom J., Northy S. et al. Frequency of autibiotic associated diarrhea in 2462 antibiotic-treated hospitalized patients a prospective study. J. Antimicrob. Chemother. 2001; 47: 48–50.Wistrom J., Northy S. et al. Frequency of autibiotic associated diarrhea in 2462 antibiotic-treated hospitalized patients a prospective study. J. Antimicrob. Chemother. 2001; 47: 48–50.Acar J.F. A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora. Chemother. 2001; 47 (3): 15–23.Acar J.F. A comparison of side effects of levofloxacin to other agents concerning the ecological and microbiological effects on normal human flora. Chemother. 2001; 47 (3): 15–23.Golledge C.L., Carson C.F., Oneill G.L. et al. Ciprofloxacin and Clostridium difficile-associated diarrhoea. J. Antimicrob. Chemother. 1992; 30: 141–147.Golledge C.L., Carson C.F., Oneill G.L. et al. Ciprofloxacin and Clostridium difficile-associated diarrhoea. J. Antimicrob. Chemother. 1992; 30: 141–147.Boenning D.A., Fleisher G.G., Campos J.M. et al. Clostridium difficile in a pediatric outpatient population. Pediatr. Infect. Dis. 1982; 1: 336–338.Boenning D.A., Fleisher G.G., Campos J.M. et al. Clostridium difficile in a pediatric outpatient population. Pediatr. Infect. Dis. 1982; 1: 336–338.Малов В.А. Антибиотик–ассоциированные диареи. Клин. микробиол. 2002; 4 (1): 185–197.Малов В.А. Антибиотик–ассоциированные диареи. Клин. микробиол. 2002; 4 (1): 185–197.Ивашкин В.Т., Шептулин А.А., Склянская О.А. Синдром диареи. М.: ГЭОТАР–Медиа. 2002. 168 с.Ивашкин В.Т., Шептулин А.А., Склянская О.А. Синдром диареи. М.: ГЭОТАР–Медиа. 2002. 168 с.Корниенко Е.В. Механизмы воздействия антибиотиков на кишечник, роль энтерола в профилактике и лечении антибиотик-ассоциированной диареи у детей. Фарматека. 2002; 10: 33–37.Корниенко Е.В. Механизмы воздействия антибиотиков на кишечник, роль энтерола в профилактике и лечении антибиотик-ассоциированной диареи у детей. Фарматека. 2002; 10: 33–37.Лузина Е.В. Антибиотик-ассоциированная диарея. Сибирский медицинский журнал. 2009; 2: 122–124.Лузина Е.В. Антибиотик-ассоциированная диарея. Сибирский медицинский журнал. 2009; 2: 122–124.Белоусова Е.А., Златкина А.Р. Синдром диареи в практике гастроэнтеролога: патофизиология и дифференцированный подход к лечению. Фарматека. 2003; 10: 65–71.Белоусова Е.А., Златкина А.Р. Синдром диареи в практике гастроэнтеролога: патофизиология и дифференцированный подход к лечению. Фарматека. 2003; 10: 65–71.Парфенов А.И., Ручкина И.Н., Осипов Г.А. Коррекция микрофлоры кишечника пробиотиками у больных антибиотик-ассоциированной диареей. Справочник поликлинического врача. 2006. С. 2.Парфенов А.И., Ручкина И.Н., Осипов Г.А. Коррекция микрофлоры кишечника пробиотиками у больных антибиотик-ассоциированной диареей. Справочник поликлинического врача. 2006. С. 2.Шульпекова Ю.О. Антибиотик–ассоциированная диарея. РМЖ. 2007; 15 (6): 1–6.Шульпекова Ю.О. Антибиотик–ассоциированная диарея. РМЖ. 2007; 15 (6): 1–6.Bartlett J.G. Antubiotic–associated diarrhea. N. Engl. J. Med. 2002; 346: 334–339.Bartlett J.G. Antubiotic–associated diarrhea. N. Engl. J. Med. 2002; 346: 334–339.Barbut F., Petit J.C. Epidemiology of Clostridium difficile nosocomial infections. Presse Med. 1996; 25 (8): 385–392.Barbut F., Petit J.C. Epidemiology of Clostridium difficile nosocomial infections. Presse Med. 1996; 25 (8): 385–392.Корниенко Е.А. Современные принципы выбора пробиотиков. Детские инфекции. 2007; 3: 64-69.Корниенко Е.А. Современные принципы выбора пробиотиков. Детские инфекции. 2007; 3: 64-69.Лобзин Ю.В., Захаренко С.М., Иванов Г.А. Современные представления об инфекции Clostridium difficile. Клин. микробиол. и антимикроб. химиотер. 2002; 3: 200–232.Лобзин Ю.В., Захаренко С.М., Иванов Г.А. Современные представления об инфекции Clostridium difficile. Клин. микробиол. и антимикроб. химиотер. 2002; 3: 200–232.Stark P.L., Lee A., Parsonage B.D. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect. Immun. 1982; 35: 895–899.Stark P.L., Lee A., Parsonage B.D. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect. Immun. 1982; 35: 895–899.Hell M., Sickau K., Chmelizek G. et al. Absence of Clostridium difficile stool carriage in asymptomatic volunteers. FMC. Proceedings. 2011; 5 (6): 183.Hell M., Sickau K., Chmelizek G. et al. Absence of Clostridium difficile stool carriage in asymptomatic volunteers. FMC. Proceedings. 2011; 5 (6): 183.Frost F., Craun G.F., Calderon R.L. Increasing hospitalizacion and death possibly due to Clostridium difficile diarrheal disease. EID. 1998; 4 (3): 619–625.Frost F., Craun G.F., Calderon R.L. Increasing hospitalizacion and death possibly due to Clostridium difficile diarrheal disease. EID. 1998; 4 (3): 619–625.Hirschorn L.R., Trnka Y., Onderdonk A. et al. Epidemiology of community-acquired Clostridium difficile associated diarrhea. J. Infect. Dis. 1994; 169: 127–133.Hirschorn L.R., Trnka Y., Onderdonk A. et al. Epidemiology of community-acquired Clostridium difficile associated diarrhea. J. Infect. Dis. 1994; 169: 127–133.Dubberke E.R., Butler A.M., Reske K.A. et al. Attributable outcomes of endemic Clostridium difficile associated disease in nonsurgical patients. Emerg. Infect. Dis. 2008, 14: 1031–1038.Dubberke E.R., Butler A.M., Reske K.A. et al. Attributable outcomes of endemic Clostridium difficile associated disease in nonsurgical patients. Emerg. Infect. Dis. 2008, 14: 1031–1038.Kuntz J.L., Chrischilles E.A., Pendergast J.F. et al. Incidence of and risk factors for community–associated Clostridium difficile infection: A nested case control study. BMC. Infectious. Dis. 2011; 11: 194.Kuntz J.L., Chrischilles E.A., Pendergast J.F. et al. Incidence of and risk factors for community–associated Clostridium difficile infection: A nested case control study. BMC. Infectious. Dis. 2011; 11: 194.Loo V.G., Poirier L., Miller M.A. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005; 353: 2442–2449.Loo V.G., Poirier L., Miller M.A. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005; 353: 2442–2449.Nelson R. Antibiotics for treatment Clostridium difficile-associated diarrhea at adults. Kokranovsky Database Syst. Rev. Release 3. 2007. CD004610.Nelson R. Antibiotics for treatment Clostridium difficile-associated diarrhea at adults. Kokranovsky Database Syst. Rev. Release 3. 2007. CD004610.Парфенов И.А., Ручкина И.Н., Осипов Г.А. Антибиотик-ассоциированная диарея и псевдомембранозный колит. Consilium Medicum. 2002; 2: 24–27.Парфенов И.А., Ручкина И.Н., Осипов Г.А. Антибиотик-ассоциированная диарея и псевдомембранозный колит. Consilium Medicum. 2002; 2: 24–27.Pepin J., Saheb N., Coulombe M.S.A. et al. Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile–associated diarrhea: A Cohort Study during an Epidemic in Quebec. Clin. Infect. Dis. 2005; 41: 1254–1260.Pepin J., Saheb N., Coulombe M.S.A. et al. Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile–associated diarrhea: A Cohort Study during an Epidemic in Quebec. Clin. Infect. Dis. 2005; 41: 1254–1260.Goorhuis A., Bakker D., Corver J. et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clinical Infectious Diseases. 2008; 47: 1162–1170.Goorhuis A., Bakker D., Corver J. et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clinical Infectious Diseases. 2008; 47: 1162–1170.Stabler R.A., He M., Dawson L. et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biology. 2009; 10: 102.Stabler R.A., He M., Dawson L. et al. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biology. 2009; 10: 102.Brazier J.S., Patel B., Pearson A. Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro. Surveil. 2007; 12 (4): 070426.Brazier J.S., Patel B., Pearson A. Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Euro. Surveil. 2007; 12 (4): 070426.Cartman S.T., Heap J.T., Kuehne S.A. et al. The emergence of hypervirulence in Clostridium difficile. Int. J. Med. Microbiol. 2010; 300 (6): 387–395.Cartman S.T., Heap J.T., Kuehne S.A. et al. The emergence of hypervirulence in Clostridium difficile. Int. J. Med. Microbiol. 2010; 300 (6): 387–395.Kuijper E.J., Coignard B., Tüll P. ESCMID Study Group for Clostridium difficile. EU Member States, European Centre for Disease Prevention and Control: Emergence of Clostridium difficile–associated disease in North America and Europe. 2007.Kuijper E.J., Coignard B., Tüll P. ESCMID Study Group for Clostridium difficile. EU Member States, European Centre for Disease Prevention and Control: Emergence of Clostridium difficile–associated disease in North America and Europe. 2007.Surawicz M.C., Elmer G.W., Speelman P. et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989; 96: 981–988.Surawicz M.C., Elmer G.W., Speelman P. et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology. 1989; 96: 981–988.Surawicz M.C., McFarland L.V., Greenberg R. et al. Prevention of beta lactam associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 1995; 90: 439-438.Surawicz M.C., McFarland L.V., Greenberg R. et al. Prevention of beta lactam associated diarrhea by Saccharomyces boulardii compared with placebo. Am. J. Gastroenterol. 1995; 90: 439-438.Бельмер С.В. Антибиотик–ассоциированный дисбактериоз кишечника. РМЖ. 2004; 12 (3): 148–151.Бельмер С.В. Антибиотик–ассоциированный дисбактериоз кишечника. РМЖ. 2004; 12 (3): 148–151.Teasley D.G., Gerding D.N., Olson M.N. et al. Prospective randomized trial of metronidazole versus vancomicin for Clostridium difficile associated diarrhea and colitis. Lancet. 1983; 2: 1043–1046.Teasley D.G., Gerding D.N., Olson M.N. et al. Prospective randomized trial of metronidazole versus vancomicin for Clostridium difficile associated diarrhea and colitis. Lancet. 1983; 2: 1043–1046.Daniels J., Pristas A. Successful treatment of Clostridium difficile colitis with ciprofloxacin. J. Clin. Gastroenterol. 1992; 15: 176–177.Daniels J., Pristas A. Successful treatment of Clostridium difficile colitis with ciprofloxacin. J. Clin. Gastroenterol. 1992; 15: 176–177.Dion Y.M., Richards G.K., Prentis J.J. et al. The influence of oral versus parenteral preoperative metronidazole on sepsis following colon surgery. Ann. Surg. 1980; 192: 221–226.Dion Y.M., Richards G.K., Prentis J.J. et al. The influence of oral versus parenteral preoperative metronidazole on sepsis following colon surgery. Ann. Surg. 1980; 192: 221–226.Bolton R.P., Culshaw M.A. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986; 27: 1169–1172.Bolton R.P., Culshaw M.A. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986; 27: 1169–1172.Wenisch C., Parschalk B., Hasenhundl M. et al. Comparison of vancomycin, teicoplanin, metronidazole and fusidic acid for the treatment of Clostridium difficile associated diarrhea. Clin. Infect. Dis. 1996; 22: 813-818.Wenisch C., Parschalk B., Hasenhundl M. et al. Comparison of vancomycin, teicoplanin, metronidazole and fusidic acid for the treatment of Clostridium difficile associated diarrhea. Clin. Infect. Dis. 1996; 22: 813-818.Department of Health. Clostridium difficile infection: how to deal with the problem. Scand. J. Infect. Dis. 2009; 41: 158–159.Department of Health. Clostridium difficile infection: how to deal with the problem. Scand. J. Infect. Dis. 2009; 41: 158–159.URL:http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_093220 (accessed 11th February 2009).URL:http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_093220 (accessed 11th February 2009).Cloud J., Kelly C. The renewed information about Clostridium difficile connected illnesses. Curr. OPIN Gastroenterol. 2007; 23: 4–9.Cloud J., Kelly C. The renewed information about Clostridium difficile connected illnesses. Curr. OPIN Gastroenterol. 2007; 23: 4–9.Buggy B.P., Fekety R., Silva J. Therapy of relapsing Clostridium difficile–associated diarrhea and colitis with the combination of vancomycin and rifampin. J. Clin. Gastroenterol. 1987; 9: 155–159.Buggy B.P., Fekety R., Silva J. Therapy of relapsing Clostridium difficile–associated diarrhea and colitis with the combination of vancomycin and rifampin. J. Clin. Gastroenterol. 1987; 9: 155–159.Lagrotteria D., Holmes S., Smieja M. et al. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile–associated diarrhea. Clin. Infect. Dis. 2006; 43: 547–552.Lagrotteria D., Holmes S., Smieja M. et al. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile–associated diarrhea. Clin. Infect. Dis. 2006; 43: 547–552.Blossom D.B., McDonald L.K. The problems connected with reviving Clostridium difficile infection. Clin. Infect. Dis. 2007; 45 (2): 222–227.Blossom D.B., McDonald L.K. The problems connected with reviving Clostridium difficile infection. Clin. Infect. Dis. 2007; 45 (2): 222–227.McFarland L.V. Alternative methods of treatment for Clostridium difficile infection. Med. Microbiol. 2005; 54: 101.McFarland L.V. Alternative methods of treatment for Clostridium difficile infection. Med. Microbiol. 2005; 54: 101.Маев И.В., Самсонов А.А., Голубев Н.Н. Антибиотик–ассоциированная диарея. Consilium medicum. 2007; 9 (1).Маев И.В., Самсонов А.А., Голубев Н.Н. Антибиотик–ассоциированная диарея. Consilium medicum. 2007; 9 (1).Cremonini F., Di Caro S., Nista E.C. et al. Meta-analysis: the effect of probiotic administration on antibiotic–associated diarrhea. Aliment. Pharmacol. Ther. 2002; 16: 1461–1467.Cremonini F., Di Caro S., Nista E.C. et al. Meta-analysis: the effect of probiotic administration on antibiotic–associated diarrhea. Aliment. Pharmacol. Ther. 2002; 16: 1461–1467.D′Souza A., Rajkumar C., Cooke J. et al. Probiotics in prevention of antibiotic-associated diarrhea: meta–analysis. BMJ. 2002; 324 (8): 1361.D′Souza A., Rajkumar C., Cooke J. et al. Probiotics in prevention of antibiotic-associated diarrhea: meta–analysis. BMJ. 2002; 324 (8): 1361.McNalty C., Logan M., Donald I.P. et al. Successful management Clostridium difficile infections at elderly therapies by use restrictive a policy antibiotic. J. Antimicrob. Chemother. 1997; 40: 707–711.McNalty C., Logan M., Donald I.P. et al. Successful management Clostridium difficile infections at elderly therapies by use restrictive a policy antibiotic. J. Antimicrob. Chemother. 1997; 40: 707–711.Larson H.E. Barclay F.E., Honour P. et al. Epidemiology of Clostridium difficile in infants. J. Infect. Dis. 1982; 146: 727–733.Larson H.E. Barclay F.E., Honour P. et al. Epidemiology of Clostridium difficile in infants. J. Infect. Dis. 1982; 146: 727–733.
The authors declare that there are no conflicts of interest present.